| Entry |
|
|---|
| Name |
Lomustine (USP/INN);
Gleostine (TN) |
|---|
| Product |
|
|---|
| Formula |
C9H16ClN3O2
|
|---|
| Exact mass |
233.0931
|
|---|
| Mol weight |
233.6952
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Class |
|
|---|
| Remark |
|
|---|
| Efficacy |
Antineoplastic, Alkylating agent |
|---|
| Disease |
Hodgkin's lymphoma [DS: H00007] |
|---|
| Comment |
Nitrosourea
|
|---|
| Target |
DNA |
|---|
| Interaction |
|
|---|
| Structure map |
| map07040 | Antineoplastics - alkylating agents |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01A ALKYLATING AGENTS
L01AD Nitrosoureas
L01AD02 Lomustine
D00363 Lomustine (USP/INN) <US>
USP drug classification [BR:br08302]
Antineoplastics
Alkylating Agents
Lomustine
D00363 Lomustine (USP/INN)
Drug groups [BR:br08330]
Antineoplastic
DG01677 Alkylating agent
DG01724 Nitrosourea
D00363 Lomustine
|
|---|
| Other DBs |
|
|---|
| KCF data |
ATOM 15
1 C1y C 27.1232 -19.0393
2 N1b N 28.3313 -19.7339
3 C1x C 25.9152 -19.7339
4 C1x C 27.1232 -17.6387
5 C5a C 29.5394 -19.0335
6 C1x C 24.7070 -19.0393
7 C1x C 25.9152 -16.9441
8 N1c N 30.7535 -19.7339
9 O5a O 29.5394 -17.6387
10 C1x C 24.7070 -17.6387
11 C1b C 31.9616 -19.0335
12 N2b N 30.7535 -21.1288
13 C1b C 33.1698 -19.7339
14 X Cl 34.3779 -19.0335
15 O3a O 29.5186 -21.8418
BOND 15
1 1 2 1
2 1 3 1
3 1 4 1
4 2 5 1
5 3 6 1
6 4 7 1
7 5 8 1
8 5 9 2
9 6 10 1
10 8 11 1
11 8 12 1
12 11 13 1
13 13 14 1
14 7 10 1
15 12 15 2
|
|---|
